Congruence Therapeutics to Present at Multiple Upcoming Investor Conferences

MONTREAL, March 27, 2024 /PRNewswire/ -- Congruence Therapeutics, a computationally-driven biotechnology company building a unique pipeline of transformative small molecule correctors rationally designed to rescue aberrant protein function, announced today that it will participate in the...
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news